Profile
FLGC ZTS TAK HLN TEVA ITCI
Company Name Flora Growth Corp. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $13.54M $73.16B $47.84B $46.09B $19.51B $14.05B
Employees 0.06K 13.80K 49.28K 24.56K 37.00K 0.86K
CEO Clifford A. Starke Ms. Kristin C. Peck Mr. Christophe Weber Brian James McNamara Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
FLGC ZTS TAK HLN TEVA ITCI
Quant Rating Score 1 3 3 3 2 1
Quant Rating Strong Sell Neutral Neutral Neutral Sell Strong Sell
Trading
FLGC ZTS TAK HLN TEVA ITCI
Last Close $0.5951 $159.18 $15.34 $10.25 $17.01 $131.87
High 52 $2.03 $196.48 $15.46 $11.41 $22.77 $131.91
Low 52 $0.46 $144.45 $12.89 $8.47 $12.82 $69.56
Price vs. 52 Week High -70.68 % -18.98 % -0.78 % -10.17 % -25.3 % -0.03 %
Price vs. 52 Week Low 29.37 % 10.2 % 19.01 % 21.02 % 32.68 % 89.58 %
Total Return
FLGC ZTS TAK HLN TEVA ITCI
1 Month Return -4.63 % -5.63 % 2.33 % -7.7 % -1.39 % 0 %
3 Month Return 21.2 % 4.91 % 4.21 % 3.64 % 23.26 % 0 %
6 Month Return -45.9 % -2.53 % 15.69 % 8.35 % -19.92 % 57.51 %
9 Month Return -61.85 % -16.23 % 6.31 % -1.16 % -2.74 % 80.92 %
YTD Return -42.22 % -2.3 % 15.86 % 7.44 % -22.82 % 57.89 %
1 Year Return -35.32 % -9.02 % 16.12 % 21.02 % 3.72 % 89.58 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
FLGC ZTS TAK HLN TEVA ITCI
Dividend Yield Percentage (TTM) - 1.13 % 4.52 % 0.01 % - -
Dividend Paid and Capex Coverage Ration (TTM) -90.67 % 2 % 1.65 % - 2.53 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 196 % 0.05 % - -
Payout Ratio (TTM) - 32.25 % 280.28 % - - -
Profitability
FLGC ZTS TAK HLN TEVA ITCI
Gross Profit Margin TTM 21.65 % 70.2 % 54.7 % 61.52 % 49.17 % 91.63 %
Return on Assets TTM -59.35 % 17.86 % 0.76 % 4.2 % -3.35 % -5.46 %
Return on Equity TTM -255.26 % 51.32 % 1.48 % 8.73 % -21.38 % -7.4 %
Return on Capital Employed TTM -109.79 % 32.08 % 3.75 % 7.74 % 1.59 % -10.05 %
Net Income Per EBT TTM 98.03 % 78.79 % 61.12 % 75.5 % 246.36 % 100.64 %
EBT Per Ebit TTM 125.95 % 92.99 % 40.08 % 86.58 % -120.28 % 63.57 %
EBIT Per Revenue TTM -20.21 % 37.01 % 9.62 % 19.64 % 2.61 % -17.15 %
Cash Flow To Debt Ratio TTM -122.29 % 43.63 % 21.32 % - 7.47 % -430.93 %
Receivables Turnover TTM 13.15 6.82 6.32 5.9 4.91 4.09
Payables Turnover TTM - 6.51 4.36 2.19 3.69 2.18
Inventory Turnover TTM 8.71 1.16 1.7 3.63 2.6 2.17
Fixed Asset Turnover TTM 2860.37 % 253.65 % 232.78 % 584.75 % 332.7 % 4569.25 %
Asset Turnover TTM 237.82 % 65.87 % 32.15 % 32.73 % 43.25 % 49.79 %
Operating Cash Flow Per Share TTM -0.34 6.58 608.55 - 1.11 -0.71
Free Cash Flow Per Share TTM -0.34 5.1 443.26 - 0.67 -0.71
Cash Per Share TTM 19.28 % 384.5 % 24349.44 % 24.05 % 149.12 % 970.67 %
Operating Cash Flow Sales Ratio TTM -12.05 % 31.71 % 21.01 % - 7.62 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.09 % 77.45 % 72.84 % - 60.43 % 100.44 %
Cash Flow Coverage Ratios TTM -122.29 % 43.63 % 21.32 % - 7.47 % -430.93 %
Price To Free Cash Flows Ratio TTM -2.09 32.07 9.73 - 25.65 -191.12
Price To Operating Cash Flows Ratio TTM -1.78 24.98 7.13 - 15.38 -185.85
Price Cash Flow Ratio TTM -1.78 24.98 7.13 - 15.38 -185.85
Income Statement (TTM)
FLGC ZTS TAK HLN TEVA ITCI
Revenue $0.06B $9.26B $4263.76B $11.23B $16.54B $0.68B
Gross Profit $0.01B $6.54B $2832.26B $6.95B $8.06B $0.62B
Gross Profit Ratio 21% 70.62% 66.43% 61.85% 48.74% 91.63%
EBITDA $-0.02B $3.87B $874.6B $2.51B $0.72B $-0.12B
Net Income $-0.02B $2.49B $144.07B $1.44B $-1.64B $-0.07B
EPS Diluted -1.3 5.47 45.58 0.32 -1.45 -0.72
Balance Sheet (MRQ)
FLGC ZTS TAK HLN TEVA ITCI
Long Term Debt $0B $5.39B $5029.93B $8.54B $16.3B $0.01B
Total Liabilities $0.02B $9.47B $7834.79B $18.09B $33.61B $0.22B
Total Equity $0B $4.77B $7274.01B $16.22B $5.72B $1.15B
Total Investments $0B $0B $445.7B $0.08B $0B $0.69B
Total Debt $0B $6.74B $4843.75B $10.1B $18.08B $0.02B
Total Assets $0.03B $14.24B $15108.79B $34.32B $39.33B $1.37B
Cash Flow Statement (TTM)
FLGC ZTS TAK HLN TEVA ITCI
Net Income $-0.02B $2.5B $144.07B $1.44B $-1.96B $-0.07B
Inventory $0B $-0.04B $-115.74B $0.22B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-287.19B $-0.57B $0B $0B
Operating Cash Flow $-0.01B $2.95B $716.34B $2.3B $1.25B $-0.07B
Capital Expenditure $-0B $-0.66B $-480.73B $-0.25B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.54
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.37
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 9.19
ALVOW Alvotech 1.73
AMPH Amphastar Pharmaceuticals, Inc. 23.2
AMRX Amneal Pharmaceuticals, Inc. 8.42
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 65.28
APUS Apimeds Pharmaceuticals US, Inc 1.78
AQST Aquestive Therapeutics, Inc. 3.72
ASRT Assertio Holdings, Inc. 0.653
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 8.93
ETFs With Exposure to FLGC
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0.00005 197.5
POTX Global X Cannabis ETF 0.69 5.15
YOLO AdvisorShares Pure Cannabis ETF 0.18 1.98
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00005 149.82
MJUS ETFMG U.S. Alternative Harvest ETF 3.28 0.7595
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00005 149.83
VEMPX Vanguard Extended Market Index InstlPlus 0.00005 369.73
Unlock